Your browser doesn't support javascript.
loading
Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial.
Frånlund, Maria; Månsson, Marianne; Godtman, Rebecka Arnsrud; Aus, Gunnar; Holmberg, Erik; Kollberg, Karin Stinesen; Lodding, Pär; Pihl, Carl-Gustaf; Stranne, Johan; Lilja, Hans; Hugosson, Jonas.
Afiliación
  • Frånlund M; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Månsson M; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Godtman RA; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Aus G; Department of Urology, Carlanderska Hospital, Gothenburg, Sweden.
  • Holmberg E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Kollberg KS; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Lodding P; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Pihl CG; Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Stranne J; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Lilja H; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hugosson J; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
J Urol ; 208(2): 292-300, 2022 08.
Article en En | MEDLINE | ID: mdl-35422134
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2022 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2022 Tipo del documento: Article País de afiliación: Suecia